Enzyvant secures new Regenerative Medicine Advanced Therapy (RMAT) designation
Enzyvant has claimed the second-ever Regenerative Medicine Advanced Therapy (RMAT) designation, a new regulatory program ushered in as part of the 21st Century Cures Act.